Dogma and innovation in the global control of tuberculosis: discussion paper.
作者信息
Grange J M, Stanford J L
机构信息
Department of Microbiology, National Heart and Lung Institute, Royal Brompton Hospital, London, UK.
出版信息
J R Soc Med. 1994 May;87(5):272-5. doi: 10.1177/014107689408700512.
Abstract
摘要
相似文献
1
Dogma and innovation in the global control of tuberculosis: discussion paper.全球结核病控制中的教条与创新：讨论文件
J R Soc Med. 1994 May;87(5):272-5. doi: 10.1177/014107689408700512.
2
The development and impact of tuberculosis vaccines.结核病疫苗的研发与影响
Cell. 2006 Feb 24;124(4):683-7. doi: 10.1016/j.cell.2006.02.013.
3
Interrupted BCG vaccination is a major threat to global child health.卡介苗接种中断对全球儿童健康构成重大威胁。
Lancet Respir Med. 2016 Apr;4(4):251-3. doi: 10.1016/S2213-2600(16)00099-0. Epub 2016 Mar 23.
4
[The efficacy, complications and prospects for the vaccinal prevention of tuberculosis].[结核病疫苗预防的疗效、并发症及前景]
Zh Mikrobiol Epidemiol Immunobiol. 1997 Nov-Dec(6):111-6.
5
[Is it possible that BCG vaccine protects against COVID-19?].卡介苗能预防新冠病毒吗？
Ned Tijdschr Geneeskd. 2020 Oct 7;164:D5552.
6
The influence of vaccination against tuberculosis with the Bacillus-Calmette-Guérin(BCG) vaccine on COVID-19 incidence and mortality - review of the literature.卡介苗（BCG）接种对COVID-19发病率和死亡率的影响——文献综述
Przegl Epidemiol. 2020;74(2):290-302. doi: 10.32394/pe.74.22.
7
Confronting the scientific obstacles to global control of tuberculosis.直面全球结核病控制的科学障碍。
J Clin Invest. 2008 Apr;118(4):1255-65. doi: 10.1172/JCI34614.
8
Bacille Calmette-Guérin (BCG) vaccine and the COVID-19 pandemic: responsible stewardship is needed.卡介苗（BCG）疫苗与新冠疫情：需要负责任的管理。
Int J Tuberc Lung Dis. 2020 Jul 1;24(7):732-734. doi: 10.5588/ijtld.20.0267.
9
A novel TB vaccine; towards a strategy based on our understanding of BCG failure.一种新型结核病疫苗；基于我们对卡介苗失效的理解制定策略。
Vaccine. 2002 Nov 22;21(1-2):7-14. doi: 10.1016/s0264-410x(02)00447-4.
10
Mycobacterium tuberculosis infection and vaccine development.结核分枝杆菌感染与疫苗研发
Tuberculosis (Edinb). 2016 May;98:30-41. doi: 10.1016/j.tube.2016.02.005. Epub 2016 Feb 27.
引用本文的文献
1
Current trends in the management of tuberculosis.结核病管理的当前趋势
J R Soc Med. 1994 Dec;87(12):733-6.
本文引用的文献
1
The emergence of drug-resistant tuberculosis in New York City.纽约市耐药结核病的出现。
N Engl J Med. 1993 Feb 25;328(8):521-6. doi: 10.1056/NEJM199302253280801.
2
Old plague, new plague, and a treatment for both?古老的瘟疫、新型的瘟疫，以及针对二者的一种治疗方法？
AIDS. 1993 Sep;7(9):1275-7.
3
Mycobacterium chelonei.龟分枝杆菌
Tubercle. 1981 Dec;62(4):273-6. doi: 10.1016/s0041-3879(81)80007-4.
4
How environmental mycobacteria may predetermine the protective efficacy of BCG.环境分枝杆菌如何预先决定卡介苗的保护效力。
Tubercle. 1981 Mar;62(1):55-62. doi: 10.1016/0041-3879(81)90037-4.
5
What is BCG?
Tubercle. 1983 Jun;64(2):129-39. doi: 10.1016/0041-3879(83)90038-7.
6
Leprosy and tuberculosis--an epidemiological comparison.麻风病与结核病——一项流行病学比较。
Tubercle. 1984 Jun;65(2):137-53. doi: 10.1016/0041-3879(84)90067-9.
7
Ten-year results during the introduction of chemotherapy for tuberculosis.结核病化疗引入期间的十年结果。
Tubercle. 1971 Jun;52(2):73-87. doi: 10.1016/0041-3879(71)90015-8.
8
Suppressor determinants of mycobacteria and their potential relevance to leprosy.分枝杆菌的抑制性决定簇及其与麻风病的潜在相关性。
Lepr Rev. 1986 Jun;57(2):147-57. doi: 10.5935/0305-7518.19860018.
9
Vaccination and skin test studies on the children of leprosy patients.
Int J Lepr Other Mycobact Dis. 1989 Mar;57(1):38-44.
10
Tuberculosis and HIV. The cursed duet.结核病与艾滋病病毒。这对该死的组合。
Bull Int Union Tuberc Lung Dis. 1990 Mar;65(1):25-8.
Zotero 插件